Newsmakers

Stephen Parodi, MD, associate executive director and infectious disease specialist with The Permanente Medical Group, explains the uses of data to determine whether social distancing is working in a Politico story published today.

Wendy Smith, MD, an otolaryngologist with The Permanente Medical Group, discussed new evidence that symptoms of the coronavirus may affect the senses of smell and taste, in a story on the ABC News website.

Nancy Gin, MD, and Joshua Mansour, MD, shared their insights on “flattening the curve” and treatment for coronavirus with Healthline.

Stephen M. Parodi, MD, associate executive director for The Permanente Medical Group, shared with Time magazine some of the ways Kaiser Permanente is using telemedicine to help combat the spread of coronavirus.

Stephen M. Parodi, MD, an infectious diseases physician with The Permanente Medical Group who is leading Kaiser Permanente’s response to the COVID-19 pandemic, explains the organization’s mitigation strategies in a Business Insider story today.

Nancy Gin, MD, chief quality officer for The Permanente Federation, explained in a Los Angeles Times story that people should only quarantine themselves when COVID-19 symptoms start to appear.

Stephen M. Parodi, MD, and Vincent Liu, MD, both of The Permanente Medical Group, published a peer-reviewed viewpoint online in JAMA on the urgent need for public health officials and large health care systems to move from containment to mitigation of the new coronavirus that causes COVID-19.

Health care and physician leaders discuss how organizations ramp up telemedicine use during the coronavirus outbreak.

On a recent episode of NPR’s Weekend Edition Saturday, Lisa A. Jackson, MD, an internist with Washington Permanente Medical Group, shared her insights on the race among scientists to develop a vaccine for the new coronavirus that leads to COVID-19 disease.